Eurobond

Thermo Fisher Scientific (NYSE: TMO) announced the pricing of a €2.1 billion euro-denominated notes offering via its finance subsidiary. The offering includes €1 billion in floating rate notes due 2027 and €1.1 billion in 3.628% fixed rate notes due 2035, both priced at 100%. Closing is expected around December 1, 2025, subject to conditions. Proceeds are intended for general corporate purposes, including potential acquisitions, debt management, and capital investments.